Measuring the Impact of Pharmacovigilance Activities, EMA, London
Dec 8, 2016
Dr. Jan Petracek shared his expertise in London at an international workshop on measuring the impact of pharmacovigilance activities. The workshop was organized by the European Medicine Agency on December 5-6, 2016. The event was web-streamed from the EMA premises in London.
In January 2016, the Pharmacovigilance Risk Assessment Committee (PRAC) adopted a strategy for measuring the impact of pharmacovigilance activities which relies on a collaborative approach between stakeholders. This workshop facilitated the implementation of the PRAC strategy with a particular focus on the development of methodologies and on stakeholder collaboration.